Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Voltage-gated calcium channel activity and complex related genes and schizophrenia: A systematic investigation based on Han Chinese population.

Zhang T, Zhu L, Ni T, Liu D, Chen G, Yan Z, Lin H, Guan F, Rice JP.

J Psychiatr Res. 2018 Nov;106:99-105. doi: 10.1016/j.jpsychires.2018.09.020. Epub 2018 Oct 3.

PMID:
30308413
2.

A review of opioid addiction genetics.

Crist RC, Reiner BC, Berrettini WH.

Curr Opin Psychol. 2018 Aug 9;27:31-35. doi: 10.1016/j.copsyc.2018.07.014. [Epub ahead of print] Review.

PMID:
30118972
3.

Genetic Polymorphisms Associated With Constipation and Anticholinergic Symptoms in Patients Receiving Clozapine.

Solismaa A, Kampman O, Lyytikäinen LP, Seppälä N, Viikki M, Mononen N, Lehtimäki T, Leinonen E.

J Clin Psychopharmacol. 2018 Jun;38(3):193-199. doi: 10.1097/JCP.0000000000000885.

PMID:
29620694
4.

No genetic association between A118G polymorphism of μ-opioid receptor gene and schizophrenia and bipolar disorders.

Yazdani S, Salimi V, Eshraghian MR, Shayestehpour M, Pourtalebi-Firoozabadi A, Romani B, Shadab A, Aghasadeghi MR, Yavarian J.

Indian J Psychiatry. 2017 Oct-Dec;59(4):483-486. doi: 10.4103/psychiatry.IndianJPsychiatry_53_17.

5.

Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder.

Hirasawa-Fujita M, Bly MJ, Ellingrod VL, Dalack GW, Domino EF.

Clin Schizophr Relat Psychoses. Spring 2017;11(1):39-48. doi: 10.3371/1935-1232-11.1.39.

6.

Optimization and characterization of an opioid kappa receptor (OPRK1) antagonist.

Guerrero M, Urbano M, Brown SJ, Cayanan C, Ferguson J, Cameron M, Devi LA, Roberts E, Rosen H.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2013 Apr 15 [updated 2014 Sep 18].

7.

Association study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population.

Ding S, Chen B, Zheng Y, Lu Q, Liu L, Zhuge QC.

BMC Psychiatry. 2013 Apr 5;13:107. doi: 10.1186/1471-244X-13-107.

8.

Pharmacogenomics of the human µ-opioid receptor.

Kasai S, Ikeda K.

Pharmacogenomics. 2011 Sep;12(9):1305-20. doi: 10.2217/pgs.11.68. Review.

PMID:
21919606
9.

A118G polymorphism of OPRM1 gene is associated with schizophrenia.

Serý O, Prikryl R, Castulík L, St'astný F.

J Mol Neurosci. 2010 May;41(1):219-22. doi: 10.1007/s12031-010-9327-z. Epub 2010 Jan 29.

PMID:
20112002
10.

Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders.

Tanaka S, Matsunaga H, Kimura M, Tatsumi Ki, Hidaka Y, Takano T, Uema T, Takeda M, Amino N.

J Neuroimmunol. 2003 Aug;141(1-2):155-64. Erratum in: J Neuroimmunol. 2003 Nov;144(1-2):148.

PMID:
12965267

Supplemental Content

Loading ...
Support Center